Bob is a Senior Investment Manager at Brandon Capital, Australia’s largest life sciences venture capital firm.

Bob obtained his MD from the University of Melbourne. Following his neurosurgery residency in some of Australia’s top academic hospitals, he joined Nucleus Network, Australia’s largest clinical trials unit, as an investigator, overseeing over 150 clinical trials across phase 1 – 3.

Since joining Brandon Capital in 2016, Bob has played a broad role across the investment lifecycle, including company creation, execution of investments and exit pathways, including mergers, acquisitions and IPO. He has held both board and executive roles within portfolio companies, working across a range of modalities, stages, and therapeutic indications spanning pharmaceuticals and medical devices.